Atrial fibrillation, stroke, and cognition: A longitudinal population-based study of people aged 85 and older

Stroke

Volumn 38, Issue 5, 2007, Pages 1454-1460

  Rastas, Sari ^a   Verkkoniemi, Auli ^b   Polvikoski, Tuomo ^c   Juva, Kati ^b   Niinistö, Leena ^d   Mattila, Kimmo ^b   Länsimies, Esko ^e   Pirttilä, Tuula ^a,e   Sulkava, Raimo ^a,f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d Katriina Geriatric Hospital   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f RHEUMATISM FOUNDATION HOSPITAL   (Finland)

Author keywords

Atrial fibrillation; Autopsy; Dementia; Elderly; Stroke

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

AGED; ALLELE; AMBULATORY CARE; ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FINLAND; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE REGRESSION; NEUROLOGIC EXAMINATION; PATIENT EDUCATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; VASCULAR DISEASE;

AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN; CEREBROVASCULAR ACCIDENT; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34247606705     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.106.477299     Document Type: Article

References (45)

1. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D'Agostino RB. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996;27:1760-1764.
2. Shinkawa A, Ueda K, Kiyohara Y, Kato I, Sueishi K, Tsuneyoshi M, Fujishima M. Silent cerebral infarction in a community-based autopsy series in Japan: The Hisayama Study. Stroke. 1995;26:380-385.
3. Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation as independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983-988.
4. Fischer CM. Reducing risks of cerebral embolism. Geriatrics. 1979;34:59-66.
5. Feinberg WM, Seeger JF, Carmody RF, Anderson DC, Hart RG, Pearce LA. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med. 1990;150:2340-2344.
6. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 2000;31:1494-1501.
7. Zhou DH, Wang JY, Li J, Deng J, Gao C, Chen M. Study on frequency and predictors of dementia after ischemic stroke: The Chongging Stroke study. J Neurol. 2004;251:421-427.
8. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke. 1998;29:75-81.
9. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA. Dementia in stroke survivors in stroke data bank cohort: prevalence, incidence, risk factors and computed tomographic findings. Stroke. 1990;21:858-866.
10. Censori B, Manara O, Agostinis C, Camerlingo G, Mamoli A. Dementia after first stroke. Stroke. 1996;27:1205-1210.
11. Kilander L, Andren B, Nyman H, Lind L, Boberg M, Lithell H. Atrial fibrillation is an independent determinant of cognitive function: a cross-sectional study in elderly men. Stroke. 1998;29:1816-1820.
12. O'Connel EO, Gray CS, French JM, Robertson IH. Atrial fibrillation and cognitive function: case-control study. J Neurol Neurosurg Psych. 1998;65:386-389.
13. Farina E, Magni E, Ambrosini F, Manfredini R, Binda A, Sina C, Mariani C. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand. 1997;96:310-316.
14. Tilvis RS, Kähonen-Väre MH, Jolkkonen J, Valvanne J, Pitkälä KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59:268-274.
15. Ott A, Breteler MMB, de Bruyne MC, van Herskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population based study: The Rotterdam Study. Stroke. 1997;28:316-321.
16. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA. 1997;277:813-817.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Third edition-revised) DSM-III-R. Washington DC: APA; 1987.
18. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
19. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Ger Soc. 1975;23:433-441.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
21. Katz S, Ford AB, Moscowitch RW, Jackson BA, Jaffe MW. Studies of illness in the aged. JAMA. 1963;185:914-919.
22. Lawton MP, Brody EM. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
23. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med. 1995;333:1242-1247.
24. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica. 1991;82:239-259.
25. Syvänen AC, Aalto-Setälä K, Harju L, Kontula K, Söderlund H. A primer-guided nucleotide incorporation assay in genotyping of apolipoprotein E. Genomics. 1990;8:684-692.
26. Miettinen HE, Korpela K, Hämäláinen L, Kontula K. Polymorphism of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Human Genetics. 1994;94:189-192.
27. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Pantieri G, Mariani E. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord. 2006;21:51-58.
28. Piquet O, Grayson DA, Creasey H, Bennett HP, Brooks WS, Waite LM, Broe GA. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuropidemiology. 2003;22:165-171.
29. Arboix A, Miguel M, Ciscar E, Garcia-Eroles L, Massons J, Balcells M. Cardiovascular risk factors in patients aged 85 or older with ischemic stroke. Clin Neurol Neurosurg. 2006;108:638-643.
30. Marini C, Baldassarre M, Russo T, De Santis F, Sacco S, Ciancarelli I, Carolei A. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology. 2004;62:77-81.
31. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Göteborg, Sweden. Stroke. 2006;37:1663-1667.
32. Saxena R, Lewis S, Berge E, Sandercock PAG, Koudstaal PJ; for the International Stroke Trial. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32:2333-2337.
33. Qiu C, Bäckman L, Winblad B, Aguero-Torres H, Fratiglioni L. The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol. 2001;58:2034-2039.
34. Ott A, van Rossum CTM, van Harskamp F, van de Mheen H, Hofman A, Breteler MMB. Education and the incidence of dementia in a large population-based study: The Rotterdam Study. Neurology. 1999;52:663-666.
35. Miech RA, Breitner JCS, Zandi PP, Khachaturian AS, Anthony JC, Mayer L; for the Cache County Study Group. Incidence of AD may decline in the early 90s for men, later for women: The Cache County Study. Neurology. 2002;58:209-218.
36. Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003;60:1909-1915.
37. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000;21:321-330.
38. Roman G, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurology. 2002;1:426-436.
39. Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke. 2003;34:2617-2622.
40. Zhu L, Fratiglioni L, Guo Z, Winblad B, Viitanen M. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen project. Neurology. 2000;54:2103-2107.
41. Zhu L, Fratiglioni L, Guo Z, Basun H, Hedlund Corder E, Winblad B, Viitanen M. Incidence of dementia in relation to stroke and the apolipoprotein E ε4 allele in the very old: findings from a population-based longitudinal study. Stroke. 2000;31:53-60.
42. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4:752-759.
43. Hand PJ, Haisma JA, Kwan J, Lindley RI, Lamont B, Dennis MS, Wardlaw JM. Interobserver agreement for the bedside clinical assessment of suspected stroke. Stroke. 2006;37:776-780.
44. Shinar D, Gross CR, Mohr JP, Caplan LR, Price TR, Wolf PA, Hier DB, Kase CS, Fishman IG, Wolf CL, Kunitz SC. Interobserver variability in the assessment of neurologic history and examination in the stroke data bank. Arch Neurol. 1985;42:557-565.
45. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167-1171.